Their human and murine organoids successfully modeled immune checkpoint blockade with anti-PD-1 and/or anti-PD-L1 expanding and activating tumor antigen-specific TILs and eliciting tumor cytotoxicity [82]. This evidence concerns the gene CD274 and neoplasm.